Cytomegalovirus-Mediated T Cell Receptor Repertoire Perturbation Is Present in Early Life.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2020
Historique:
received: 30 03 2020
accepted: 15 06 2020
entrez: 26 10 2020
pubmed: 27 10 2020
medline: 21 4 2021
Statut: epublish

Résumé

Human cytomegalovirus (CMV) is a highly prevalent herpesvirus, particularly in sub-Saharan Africa, where it is endemic from infancy. The T cell response against CMV is important in keeping the virus in check, with CD8 T cells playing a major role in the control of CMV viraemia. Human leukocyte antigen (HLA) B

Identifiants

pubmed: 33101265
doi: 10.3389/fimmu.2020.01587
pmc: PMC7554308
doi:

Substances chimiques

Antigens, Viral 0
Epitopes, T-Lymphocyte 0
HLA Antigens 0
Peptides 0
Receptors, Antigen, T-Cell 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1587

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI133673
Pays : United States
Organisme : Wellcome Trust
ID : WT100327MA
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : PG WT104748MA
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 202485/Z/16/Z
Pays : United Kingdom

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2020 Attaf, Roider, Malik, Rius Rafael, Dolton, Predergast, Leslie, Ndung'u, Kløverpris, Sewell and Goulder.

Références

Clin Exp Immunol. 2015 Jul;181(1):1-18
pubmed: 25753381
Med J Aust. 2014 Nov 17;201(10):578-80
pubmed: 25390262
J Immunol. 2002 Aug 15;169(4):1984-92
pubmed: 12165524
J Immunol. 2003 Feb 15;170(4):2022-9
pubmed: 12574372
Front Immunol. 2018 Nov 14;9:2539
pubmed: 30487790
Rev Med Virol. 2010 Jul;20(4):202-13
pubmed: 20564615
J Infect Dis. 1994 Apr;169(4):766-8
pubmed: 8133089
J Immunol. 2019 Jan 15;202(2):476-483
pubmed: 30541882
J Immunol. 2009 Jan 15;182(2):784-92
pubmed: 19124721
J Trop Pediatr. 2018 Jun 1;64(3):215-224
pubmed: 29873796
Lancet. 2004 Jun 26;363(9427):2116-21
pubmed: 15220032
J Immunol. 2011 Feb 15;186(4):2056-2064
pubmed: 21248263
J Immunol. 2016 Jun 15;196(12):5005-13
pubmed: 27183615
Haematologica. 2014 May;99(5):795-7
pubmed: 24790056
J Exp Med. 2004 Nov 15;200(10):1347-58
pubmed: 15545358
Proc Natl Acad Sci U S A. 2006 Dec 5;103(49):18691-6
pubmed: 17130450
Eur J Immunol. 2018 Feb;48(2):258-272
pubmed: 28975614
BMC Infect Dis. 2008 Oct 15;8:139
pubmed: 18922182
J Clin Immunol. 2003 Jul;23(4):247-57
pubmed: 12959217
Int Immunol. 1998 Oct;10(10):1407-19
pubmed: 9796907
J Exp Med. 1994 Dec 1;180(6):2335-40
pubmed: 7964506
Trends Immunol. 2012 Feb;33(2):84-90
pubmed: 22222196
Sci Immunol. 2016 Dec;1(6):
pubmed: 28361127
Blood. 2015 Jun 18;125(25):3835-50
pubmed: 25852054
PLoS Pathog. 2010 Nov 18;6(11):e1001198
pubmed: 21124993
Cell Mol Immunol. 2015 Jul;12(4):391-9
pubmed: 25619506
Front Pediatr. 2018 Apr 10;6:96
pubmed: 29692984
Immunol Cell Biol. 2015 Aug;93(7):625-33
pubmed: 25801351
Clin Cancer Res. 2017 Oct 1;23(19):5779-5788
pubmed: 28679768
Blood. 2000 Apr 1;95(7):2240-5
pubmed: 10733491
Nat Methods. 2015 May;12(5):380-1
pubmed: 25924071
Nucleic Acids Res. 2018 Jan 4;46(D1):D419-D427
pubmed: 28977646
Blood. 2013 Apr 4;121(14):2796-803
pubmed: 23412093
J Immunol. 2015 Jun 1;194(11):5329-45
pubmed: 25911754
Blood. 2010 May 20;115(20):4111-9
pubmed: 20107229
Proc Natl Acad Sci U S A. 2016 Apr 19;113(16):4440-5
pubmed: 27036003
PLoS Comput Biol. 2015 Nov 25;11(11):e1004503
pubmed: 26606115
J Biol Chem. 2009 Oct 2;284(40):27281-9
pubmed: 19605354
AIDS. 2007 Jun 19;21(10):1253-61
pubmed: 17545701
Blood. 2002 Jan 1;99(1):213-23
pubmed: 11756174
AIDS. 2008 Jul 11;22(11):1333-43
pubmed: 18580613
J Exp Med. 2005 Sep 5;202(5):673-85
pubmed: 16147978
J Immunol. 2018 Apr 1;200(7):2263-2279
pubmed: 29483360
J Immunol. 2005 Jun 1;174(11):7446-52
pubmed: 15905594
PLoS One. 2017 Dec 12;12(12):e0189612
pubmed: 29232408
Exp Gerontol. 2014 Jun;54:71-4
pubmed: 24440389
J Immunol. 2006 Feb 15;176(4):2645-53
pubmed: 16456027
Medicine (Baltimore). 1984 May;63(3):155-64
pubmed: 6325849
Proc Natl Acad Sci U S A. 2014 Sep 9;111(36):13139-44
pubmed: 25157137
Front Immunol. 2018 Mar 02;9:328
pubmed: 29552009
Front Immunol. 2017 Jun 19;8:715
pubmed: 28674537
Immunity. 2018 Feb 20;48(2):202-213
pubmed: 29466753
N Engl J Med. 1993 Dec 23;329(26):1922-6
pubmed: 7902536
Cell Rep. 2017 Apr 18;19(3):569-583
pubmed: 28423320
Curr Opin Immunol. 2012 Aug;24(4):507-11
pubmed: 22541724
PLoS Pathog. 2015 Jun 15;11(6):e1004954
pubmed: 26076345
Exp Gerontol. 2014 Jun;54:90-3
pubmed: 24440387

Auteurs

Meriem Attaf (M)

Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom.
Systems Immunity Research Institute, Cardiff University, Cardiff, United Kingdom.

Julia Roider (J)

Human Immunodeficiency Virus Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
Africa Health Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
German Centre for Infection Research, Munich, Germany.
Department of Infectious Diseases, Ludwig-Maximilians-University, Munich, Germany.

Amna Malik (A)

Department of Paediatrics, University of Oxford, Oxford, United Kingdom.

Cristina Rius Rafael (C)

Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom.
Systems Immunity Research Institute, Cardiff University, Cardiff, United Kingdom.

Garry Dolton (G)

Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom.
Systems Immunity Research Institute, Cardiff University, Cardiff, United Kingdom.

Andrew J Predergast (AJ)

Zvitambo Institute for Maternal and Child Health Research, Harare, Zimbabwe.
Centre for Genomics and Child Health, Blizard Institute, Queen Mary University of London, London, United Kingdom.
Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.

Alasdair Leslie (A)

Africa Health Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
Infection and Immunity, University College London, London, United Kingdom.

Thumbi Ndung'u (T)

Human Immunodeficiency Virus Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
Africa Health Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
Infection and Immunity, University College London, London, United Kingdom.
The Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Boston, MA, United States.
Virology and Immunology, Max Planck Institute for Infection Biology, Berlin, Germany.

Henrik N Kløverpris (HN)

Africa Health Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
Infection and Immunity, University College London, London, United Kingdom.

Andrew K Sewell (AK)

Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom.
Systems Immunity Research Institute, Cardiff University, Cardiff, United Kingdom.

Philip J Goulder (PJ)

Department of Paediatrics, University of Oxford, Oxford, United Kingdom.
The Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Boston, MA, United States.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH